Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Buda

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
The Oncologist|November 17, 2025
Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel diseaseBrigida Barberio, Ilaria Patuzzi, Luisa Bertin, et al.
Journal of Clinical Medicine|March 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's DiseaseLuisa Bertin, Brigida Barberio, Alessandro Gubbiotti, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2026
Tools and Advanced Imaging Technologies for Assessing Intestinal Epithelial Barrier Integrity: A Systematic ReviewSophie Vieujean, Raja Atreya, Andrea Buda, et al.
Gut|August 2, 2018
Periendoscopic management of direct oral anticoagulants: a prospective cohort studyFranco Radaelli, Lorenzo Fuccio, Silvia Paggi, et al.
Gastrointestinal Endoscopy|May 3, 2021
Novel 1-L polyethylene glycol + ascorbate versus high-volume polyethylene glycol regimen for colonoscopy cleansing: a multicenter, randomized, phase IV studyAlessandro Repici, Cristiano Spada, Renato Cannizzaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2024
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
Annals of Internal Medicine|February 21, 2023
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort StudyManuel Zorzi, Giulio Antonelli, Claudio Barbiellini Amidei, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Oncologist|November 17, 2025
Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel diseaseBrigida Barberio, Ilaria Patuzzi, Luisa Bertin, et al.
Journal of Clinical Medicine|March 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's DiseaseLuisa Bertin, Brigida Barberio, Alessandro Gubbiotti, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2026
Tools and Advanced Imaging Technologies for Assessing Intestinal Epithelial Barrier Integrity: A Systematic ReviewSophie Vieujean, Raja Atreya, Andrea Buda, et al.
Gut|August 2, 2018
Periendoscopic management of direct oral anticoagulants: a prospective cohort studyFranco Radaelli, Lorenzo Fuccio, Silvia Paggi, et al.
Gastrointestinal Endoscopy|May 3, 2021
Novel 1-L polyethylene glycol + ascorbate versus high-volume polyethylene glycol regimen for colonoscopy cleansing: a multicenter, randomized, phase IV studyAlessandro Repici, Cristiano Spada, Renato Cannizzaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2024
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
Annals of Internal Medicine|February 21, 2023
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort StudyManuel Zorzi, Giulio Antonelli, Claudio Barbiellini Amidei, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Pageof 9